Please try another search
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
| Name | Age | Since | Title |
|---|---|---|---|
| Douglas Glen Janzen | 55 | 2013 | Chairman, CEO & President |
| Ken Patterson | - | 2018 | Member of Strategic Advisory Board |
| Iqbal K. Ahmed | - | 2018 | Chairman of Strategic Advisory Board |
| Vikram Lekhi | - | 2018 | Member of Strategic Advisory Board |
| Rosa Braga-Mele | - | 2018 | Member of Strategic Advisory Board |
| Marc Lustig | 51 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review